Clinical Trial Update: Nesiritide and Renal Function After the Total Artificial Heart [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Nesiritide and renal function after total artificial heart implantation was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome
• Heart Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Congestive Heart Failure, Cardiorenal Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2014-08-18